Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brun

Showing results (301-310 of 385) with videos related to

Pageof 39
Sort By:
AIDS (London, England)|October 30, 2003
Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapyAiming Yang, Martin S King, Lixin Han, et al.
The Journal of Hospital Infection|October 12, 2016
First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in FranceS Jolivet, M Fines-Guyon, B Nebbad, et al.
The New England Journal of Medicine|November 29, 1990
Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face maskL Brochard, D Isabey, J Piquet, et al.
Frontiers in Cardiovascular Medicine|November 24, 2025
Role of heparin-induced HGF release in the acute phase of STEMIS Leboube, A Paccalet, C Brun, et al.
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
The British Journal of Dermatology|August 12, 2016
Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patientsM Papo, L Valeyrie-Allanore, K Razazi, et al.
Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.
Acta Medica Scandinavica|January 1, 1986
Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseasesJ Gerstoft, J T Balsløv, M Brahm, et al.
Acta Medica Scandinavica|January 1, 1985
Prognosis in glomerulonephritis. A follow-up study of 395 consecutive, biopsy-verified cases. I. Classification, renal histology and outcome. Report from a Copenhagen study group of renal diseasesM Brahm, J T Balsløv, C Brun, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
Pageof 39

Showing results (301-310 of 385) with videos related to

Sort By:
Pageof 39
AIDS (London, England)|October 30, 2003
Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapyAiming Yang, Martin S King, Lixin Han, et al.
The Journal of Hospital Infection|October 12, 2016
First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in FranceS Jolivet, M Fines-Guyon, B Nebbad, et al.
The New England Journal of Medicine|November 29, 1990
Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face maskL Brochard, D Isabey, J Piquet, et al.
Frontiers in Cardiovascular Medicine|November 24, 2025
Role of heparin-induced HGF release in the acute phase of STEMIS Leboube, A Paccalet, C Brun, et al.
Revue Medicale Suisse|June 20, 2014
[The Onco-hematology clinical research unit at the Geneva University Hospital: example of a fruitful public-private partners]M Ackermann-Zare, V Ancrenaz, N Blazek, et al.
The British Journal of Dermatology|August 12, 2016
Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patientsM Papo, L Valeyrie-Allanore, K Razazi, et al.
Stroke|January 20, 2009
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?Stephan A Mayer, Stephen M Davis, Brett E Skolnick, et al.
Acta Medica Scandinavica|January 1, 1986
Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseasesJ Gerstoft, J T Balsløv, M Brahm, et al.
Acta Medica Scandinavica|January 1, 1985
Prognosis in glomerulonephritis. A follow-up study of 395 consecutive, biopsy-verified cases. I. Classification, renal histology and outcome. Report from a Copenhagen study group of renal diseasesM Brahm, J T Balsløv, C Brun, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
Pageof 39